Related Experiment Video
Updated: Jun 6, 2025
10:06
Engineering Artificial Factors to Specifically Manipulate Alternative Splicing in Human Cells
Published on: April 26, 2017
8.9K
Alternative Splicing: A Potential Therapeutic Target in Hematological Malignancies
Gazmend Temaj1, Silvia Chichiarelli2, Sarmistha Saha3
1Faculty of Pharmacy, College UBT, 10000 Prishtina, Kosovo.
Hematology Reports
|November 25, 2024
Summary
Alternative splicing alterations drive leukemia development by producing oncogenic proteins. Understanding these splicing defects is key to developing targeted therapies for better leukemia treatment outcomes.
Area of Science:
- Molecular Biology
- Oncology
- Genetics
Background:
- Leukemia is the most common childhood cancer, with acute lymphoblastic leukemia (ALL) showing significant heterogeneity.
- Alternative RNA splicing plays a crucial role in generating protein diversity, but its dysregulation is implicated in cancer.
Purpose of the Study:
- To explore the role of alternative splicing in leukemia pathogenesis.
- To highlight the impact of splicing factor mutations on cancer development and treatment resistance.
Main Methods:
- Review of literature on RNA splicing mechanisms and their role in hematological malignancies.
- Analysis of mutations in key splicing factor genes (U2AF1, SF3B1, SRSF2, ZRSR2, HNRNPH1) in leukemia.
Main Results:
- Mutations in splicing factors are frequently observed in hematological malignancies.
- Aberrant splicing leads to variant proteins that can promote oncogenesis.
- Splicing factor mutations are associated with poor prognosis and resistance to therapy.
Conclusions:
- Dysregulation of RNA splicing is a significant driver of leukemia.
- Targeting aberrant splicing mechanisms offers a promising therapeutic strategy for leukemia patients.
Related Concept Videos
01:32RNA Splicing
56.0K
Splicing is the process by which eukaryotic RNA is edited before its translation into protein. The RNA strand transcribed from eukaryotic DNA is called the primary transcript. The primary transcripts that become mRNAs are called precursor messenger RNAs (pre-mRNAs). Eukaryotic pre-mRNA contains alternating sequences of exons and introns. Exons are nucleotide sequences that code for proteins, whereas introns are the non-coding regions. In RNA splicing, introns are removed and exons are bonded...
56.0K
02:18Alternative RNA Splicing
21.0K
Alternative RNA splicing is the regulated splicing of exons and introns to produce different mature mRNAs from a single pre-mRNA. Unlike in constitutive splicing where a single gene produces a single type of mRNA, alternative splicing allows an organism to produce multiple proteins from a single gene and plays an important role in protein diversity.
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
There are five types of alternative RNA splicing that vary in the ways the pre-mRNA segments are removed or retained in the mature mRNA. The first...
21.0K
02:57Targeted Cancer Therapies
7.5K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.5K
01:22Bone Marrow Sampling and Transplants
284
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
284
01:21Stem Cell Therapy for Tissue Regeneration
4.0K
Stem cell therapy is a method used in regenerative medicine to repair and restore function to damaged tissues and organs. Stem cells have the potential to proliferate and differentiate into various tissue types, making them ideal candidates for tissue regeneration. For example, hematopoietic stem cell transplants are commonly used in blood cancer treatment to replenish damaged bone marrow and restore healthy blood cells.
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
Types of Stem Cells used in Stem Cell Therapy
The two main cell...
4.0K
01:01Regulation of Hematopoietic Stem Cells
3.1K
All blood and immune cells are produced from the multipotent hematopoietic stem cells (HSCs) by the process of hematopoiesis. However, they all have a limited life span. In addition, many are depleted in immune surveillance or combatting an injury or infection. This makes blood one of the most regenerative tissues. Hematopoiesis helps replenish these blood and immune cells, restoring the body's normal functioning. However, overproduction of blood and immune cells can make them cancerous or...
3.1K